Reply: Not All NSTEMIs Are Created Equal

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F15%3A43911048" target="_blank" >RIV/00216208:11120/15:43911048 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064173:_____/15:N0000008

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.jacc.2015.01.054" target="_blank" >http://dx.doi.org/10.1016/j.jacc.2015.01.054</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jacc.2015.01.054" target="_blank" >10.1016/j.jacc.2015.01.054</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Reply: Not All NSTEMIs Are Created Equal

Popis výsledku v původním jazyce

Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study, To answer the comments of Dr. Nairooz and colleagues, we have performed additional analyses of the percutaneous coronary intervention subgroup that need to be examined with caution considering their post-hoc nature. Although it is possible to evaluate the individual risk of a patient presenting with a non-ST-segment elevation myocardial infarction according to well-known factors or scores, making the decision to pre-treat or not, according to this evaluation does not seem appropriate. The GRACE (Global Registry of Acute Coronary Events) score, defined as high when more than 110, was not associated with lower rates of the primary endpoint at 30 days in patients who were pre-treated with prasugrel (15.66%) versus those who were not (14.08%, p value for interaction = 0.26). This was also confirmed when a GRACE score of more than 140 was considered (15.54

Název v anglickém jazyce

Reply: Not All NSTEMIs Are Created Equal

Popis výsledku anglicky

Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study, To answer the comments of Dr. Nairooz and colleagues, we have performed additional analyses of the percutaneous coronary intervention subgroup that need to be examined with caution considering their post-hoc nature. Although it is possible to evaluate the individual risk of a patient presenting with a non-ST-segment elevation myocardial infarction according to well-known factors or scores, making the decision to pre-treat or not, according to this evaluation does not seem appropriate. The GRACE (Global Registry of Acute Coronary Events) score, defined as high when more than 110, was not associated with lower rates of the primary endpoint at 30 days in patients who were pre-treated with prasugrel (15.66%) versus those who were not (14.08%, p value for interaction = 0.26). This was also confirmed when a GRACE score of more than 140 was considered (15.54

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of the American College of Cardiology

ISSN

0735-1097

e-ISSN

—

Svazek periodika

65

Číslo periodika v rámci svazku

16

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

2

Strana od-do

1718-1719

Kód UT WoS článku

000353337300027

EID výsledku v databázi Scopus

—